Perhaps the "slow" aspect of the longhaulers trial

Perhaps the "slow" aspect of the longhaulers trial, will be obtaining sites to agree to come onboard. Patients agreed, should be quite willing if not anxious, to volunteer, when learning of the safety record of leronlimab. Oh yes, and also, we need to "wait" for the FDA to approve our trial protocol. That may take 22 years.